1. Neuroleptic malignant syndrome in the elderly

   Newsletter Article 12 February 2013 Pages: 2 - 2

2. Avoidance and management of adverse reactions to drugs and diagnostic agents

   Newsletter Article 12 February 2013 Pages: 2 - 3

3. Prophylactic antimalarial use and associated adverse effects

   Newsletter Article 12 February 2013 Pages: 3 - 3

4. Erythropoietin increases cardiovascular deaths?

   Newsletter Article 12 February 2013 Pages: 3 - 4

5. Drug use in pregnancy and the neonate: evaluation of risks and benefits is required

   Newsletter Article 12 February 2013 Pages: 4 - 4

6. Amiodarone

   Newsletter Article 12 February 2013 Pages: 5 - 5

7. Anti-inflammatories, non-steroidal

   Newsletter Article 12 February 2013 Pages: 5 - 5

8. Arecoline

   Newsletter Article 12 February 2013 Pages: 5 - 5

9. Atenolol interaction

   Newsletter Article 12 February 2013 Pages: 5 - 5

10. Auranofin/ibuprofen

    Newsletter Article 12 February 2013 Pages: 5 - 6

11. Aurothiopropanol

    Newsletter Article 12 February 2013 Pages: 6 - 6

12. Azathioprine

    Newsletter Article 12 February 2013 Pages: 6 - 6

13. Bacitracin

    Newsletter Article 12 February 2013 Pages: 6 - 6

14. Bepridil

    Newsletter Article 12 February 2013 Pages: 6 - 6

15. Captopril

    Newsletter Article 12 February 2013 Pages: 6 - 6

16. Carboplatin

    Newsletter Article 12 February 2013 Pages: 6 - 6

17. Carmustine see Cisplatin/Carmustine

    Newsletter Article 12 February 2013 Pages: 6 - 6

18. Chemotherapy

    Newsletter Article 12 February 2013 Pages: 6 - 6

19. Chloroprocaine

    Newsletter Article 12 February 2013 Pages: 6 - 6

20. Cinchocaine

    Newsletter Article 12 February 2013 Pages: 7 - 7

21. Cisplatin

    Newsletter Article 12 February 2013 Pages: 7 - 7

22. Cisplatin/carmustine

    Newsletter Article 12 February 2013 Pages: 7 - 7

23. Clomipramine

    Newsletter Article 12 February 2013 Pages: 7 - 7

24. Clomipramine interaction

    Newsletter Article 12 February 2013 Pages: 7 - 7

25. Cocaine overdose

    Newsletter Article 12 February 2013 Pages: 7 - 7

26. Cotrimoxazole

    Newsletter Article 12 February 2013 Pages: 7 - 8

27. Cotrimoxazole see Methotrexate interaction

    Newsletter Article 12 February 2013 Pages: 8 - 8

28. Cyclophosphamide

    Newsletter Article 12 February 2013 Pages: 8 - 8

29. Cyclosporin

    Newsletter Article 12 February 2013 Pages: 8 - 8

30. Doxylamine overdose

    Newsletter Article 12 February 2013 Pages: 8 - 8

31. Encainide

    Newsletter Article 12 February 2013 Pages: 8 - 8

32. Ibuprofen see Auranofin/ibuprofen

    Newsletter Article 12 February 2013 Pages: 8 - 8

33. Immunoglobulin

    Newsletter Article 12 February 2013 Pages: 9 - 9

34. Interferon see Interleukin 2/interferon gamma

    Newsletter Article 12 February 2013 Pages: 9 - 9

35. Interleukin 2/interferon gamma

    Newsletter Article 12 February 2013 Pages: 9 - 9

36. Isotretinoin

    Newsletter Article 12 February 2013 Pages: 9 - 9

37. Lovastatin

    Newsletter Article 12 February 2013 Pages: 9 - 9

38. Methotrexate interaction

    Newsletter Article 12 February 2013 Pages: 9 - 9

39. Mexiletine

    Newsletter Article 12 February 2013 Pages: 9 - 9

40. Mitoxantrone

    Newsletter Article 12 February 2013 Pages: 10 - 10

41. Morphine

    Newsletter Article 12 February 2013 Pages: 10 - 10

42. Neostigmine see Atenolol interaction

    Newsletter Article 12 February 2013 Pages: 10 - 10

43. Nomifensine

    Newsletter Article 12 February 2013 Pages: 10 - 10

44. Organic nitrates

    Newsletter Article 12 February 2013 Pages: 10 - 10

45. Paraquat poisoning

    Newsletter Article 12 February 2013 Pages: 11 - 11

46. Penicillamine

    Newsletter Article 12 February 2013 Pages: 11 - 11

47. Phenelzine see Clomipramine interaction

    Newsletter Article 12 February 2013 Pages: 11 - 11

48. Phenytoin

    Newsletter Article 12 February 2013 Pages: 11 - 11

49. Piroxicam

    Newsletter Article 12 February 2013 Pages: 11 - 12

50. Procainamide

    Newsletter Article 12 February 2013 Pages: 12 - 12